Gilead’s antiviral drug Remdesiver flops in its first trial: FT

According to a report by the Financial Times, Gilead Science Inc’s experimental antiviral drug Remdesiver, which was being used to treat coronavirus, failed to improve the health of patients. Yahoo Finance’s Anjalee Khemlani joins The Final Round panel to break down the latest news about the coronavirus. …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.